|
|
|
|
  |
| NOTICES |
|
| Notice No. |
|
20170607-17 |
|
Notice Date |
|
07 Jun 2017 |
|
| Category |
|
Corporate Actions |
|
Segment |
|
Equity |
|
| Subject |
|
Scheme of Arrangement (Demerger) of Omkar Speciality Chemicals Ltd. |
|
|
|
|
|
| Content |
|
|
Trading Members of the Exchange are hereby informed that, pursuant to the Composite Scheme of Arrangement (Demerger) approved by the Hon’ble National Company Law Tribunal, Mumbai Bench, Omkar Speciality Chemicals Ltd., has fixed the Record Date for the purpose of determining entitlement of the shareholders of the Company, as per details given below:
|
COMPANY NAME
CODE
|
RECORD DATE
|
PURPOSE
|
EX-ENTITLEMENT FROM
DATE &
SETT. NO.
|
|
Omkar Speciality Chemicals Ltd.
(533317)
|
13/06/2017
|
As per Composite Scheme of Arrangement sanctioned by the Hon’ble National Company Law Tribunal, Mumbai Bench, between, Omkar Speciality Chemicals Ltd and Lasa Laboratory Private Limited and Urdhwa Chemicals Company Private Limited and Rishichem Research Limited and Desh Chemicals Private Limited and Lasa Supergenerics Limited and their respective Shareholders and Creditors: -
Upon the coming into effect of the aforesaid Scheme and in consideration of the demerger of Veterinary API Undertaking into Lasa Supergenerics Limited pursuant to this Scheme :
Lasa Supergenerics Limited shall issue and allot equity shares at par on a proportionate basis to the shareholders of Omkar Speciality Chemicals Ltd in the following proportion :
“1 (ONE) fully paid up equity share of Lasa Supergenerics Limited shall be issued and allotted for every 1 (ONE) fully paid up equity share each held in Omkar Speciality Chemicals Ltd.”
|
12/06/2017
DR-050/2017- 2018
|
Note:
Pursuant to SEBI Circular No. SEBI/Cir/ISD/1/2010 dated September 2, 2010, Trading members are hereby informed that the trading in the equity shares of the aforesaid company shall be transferred from ‘B’ group to ‘T’ group w.e.f. June 12, 2017 and pursuant to SEBI Circular No. CIR/MRD/DP/01/2012 dated January 20, 2012; the aforesaid scrip shall be a part of Call Auction in Pre-open Session on June 12, 2017.
Subject to compliance with requisite formalities the resulting company Lasa Supergenerics Limited will be listed on BSE Limited.
Mangesh Tayde
Senior Manager –Listing Operations (CRD)
Contact No. 2272 8846
07th June, 2017
|
|